Relative risk of death in the SMART study - PubMed (original) (raw)
Comment
Relative risk of death in the SMART study
Birgit Grund et al. Lancet Infect Dis. 2009 Dec.
No abstract available
Comment on
- Not so SMART?
Stebbing J, Dalgleish A. Stebbing J, et al. Lancet Infect Dis. 2009 May;9(5):268-9. doi: 10.1016/S1473-3099(09)70092-1. Lancet Infect Dis. 2009. PMID: 19393954 No abstract available.
Similar articles
- [Timing of initiation of antiretroviral therapy in HIV-1-infected patients. Meta-analysis of the When To Start Consortium].
Goebel FD, Nitschmann S. Goebel FD, et al. Internist (Berl). 2010 Apr;51(4):539-41. doi: 10.1007/s00108-010-2592-7. Internist (Berl). 2010. PMID: 20237749 German. No abstract available. - Treating children with HIV infection: what we can do, we should do.
Oleske JM. Oleske JM. Clin Infect Dis. 2007 Feb 15;44(4):605-6. doi: 10.1086/510495. Epub 2007 Jan 9. Clin Infect Dis. 2007. PMID: 17243068 No abstract available. - Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.
Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472 - Recent developments in HIV treatment, Part 2.
Boyle BA. Boyle BA. AIDS Read. 2005 Jun;15(6):277-9, 284. AIDS Read. 2005. PMID: 15962449 Review. No abstract available. - Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
When To Start Consortium; Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR. When To Start Consortium, et al. Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8. Lancet. 2009. PMID: 19361855 Free PMC article. Review.
Cited by
- HIV-associated chronic immune activation.
Paiardini M, Müller-Trutwin M. Paiardini M, et al. Immunol Rev. 2013 Jul;254(1):78-101. doi: 10.1111/imr.12079. Immunol Rev. 2013. PMID: 23772616 Free PMC article. Review. - Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy.
Ticona E, Bull ME, Soria J, Tapia K, Legard J, Styrchak SM, Williams C, Mitchell C, La Rosa A, Rosa AL, Coombs RW, Frenkel LM. Ticona E, et al. AIDS. 2015 Aug 24;29(13):1617-22. doi: 10.1097/QAD.0000000000000758. AIDS. 2015. PMID: 26372272 Free PMC article. - Elevated Foxp3+ double-negative T cells are associated with disease progression during HIV infection.
Zhang L, Wei Y, Wang D, Du J, Wang X, Li B, Jiang M, Zhang M, Chen N, Deng M, Song C, Chen D, Wu L, Xiao J, Liang H, Zhao H, Kong Y. Zhang L, et al. Front Immunol. 2022 Jul 28;13:947647. doi: 10.3389/fimmu.2022.947647. eCollection 2022. Front Immunol. 2022. PMID: 35967422 Free PMC article. - CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.
Schuler PJ, Macatangay BJ, Saze Z, Jackson EK, Riddler SA, Buchanan WG, Hilldorfer BB, Mellors JW, Whiteside TL, Rinaldo CR. Schuler PJ, et al. AIDS. 2013 Jun 19;27(10):1545-55. doi: 10.1097/QAD.0b013e328360c7f3. AIDS. 2013. PMID: 24005375 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical